More about

Hormone Therapy

News
May 08, 2020
3 min read
Save

Reproductive concerns among transgender adolescents may manifest as ‘disinterest’ in future parenthood

Reproductive concerns among transgender adolescents may manifest as ‘disinterest’ in future parenthood

A small cohort of adolescents and young adults who identify as transgender reported limited baseline knowledge of reproduction and expressed underlying reproductive concerns that may manifest as disinterest in becoming a parent, according to findings from a pilot study published in Transgender Health.

News
May 06, 2020
2 min read
Save

State-level nondiscrimination policies may decrease suicidality among gender minority individuals

Nondiscrimination policies appeared associated with a decrease or no change in suicidality among gender minority individuals living in states with these policies, according to results of a cohort study published in JAMA Psychiatry.

News
May 01, 2020
2 min read
Save

More depression reported by women with premature menopause, current HT use

Among a large cohort of Canadian women, premature menopause and current use of hormone therapy were associated with self-reported depression, according to results from a study published in Menopause.

News
April 29, 2020
2 min read
Save

Gender-affirming HT poses no hypertension risk

Gender-affirming HT poses no hypertension risk

Among a large cohort of transgender adults prescribed gender-affirming hormones, higher levels of cross-sex hormones did not increase the odds of hypertension, and hypertension diagnoses were fewer among transgender women who were ever prescribed progestins, according to data published in Transgender Health.

News
April 14, 2020
5 min read
Save

'More hopeful outcomes' on the horizon for Prader-Willi syndrome

'More hopeful outcomes' on the horizon for Prader-Willi syndrome

Prader-Willi syndrome, a neurodevelopmental disorder that occurs in about 1 in 15,000 births, is the most common genetic cause of life-threatening childhood obesity, which is just one of its complex symptoms. Still, it has proved extremely difficult to treat. Fortunately for the Prader-Willi syndrome community, researchers continue to test potential therapies to find a comprehensive treatment or a way to curb the most severe symptoms.

News
April 13, 2020
4 min read
Save

Researchers explore cognitive effects of hormone therapy for prostate cancer

Researchers explore cognitive effects of hormone therapy for prostate cancer

Androgen suppression therapy for prostate cancer, although effective, is associated with a host of systemic adverse effects.

News
April 08, 2020
2 min read
Save

Depression, suicidal ideation rates high among transgender teens

Depression, suicidal ideation rates high among transgender teens

Many adolescents who identify as transgender or gender nonconforming were identified as experiencing psychological comorbidities, such as depression, anxiety and suicidal ideation, with a greater burden observed among transgender males vs. transgender females, according to findings accepted for presentation at the Endocrine Society Annual Meeting.

News
February 24, 2020
3 min read
Save

Subsequent PFS benefit of apalutamide ‘an indicator of effective early intensive treatment’ in prostate cancer

Subsequent PFS benefit of apalutamide ‘an indicator of effective early intensive treatment’ in prostate cancer

The addition of apalutamide to androgen deprivation therapy provided a subsequent PFS benefit for men with nonmetastatic castration-resistant prostate cancer, according to results of a post-hoc analysis of the randomized phase 3 TITAN study presented at Genitourinary Cancers Symposium.

News
February 17, 2020
5 min read
Save

Controversial pubertal blocker legislation may bring unintended consequences for children

Controversial pubertal blocker legislation may bring unintended consequences for children

Several states across the country have introduced or are considering legislation that would prohibit medical treatment for children who may be transgender, including the use of pubertal blockers, a trend that has alarmed clinicians who say such bills reflect widespread misunderstandings and go against evidence-based practices.

News
February 17, 2020
2 min read
Save

Hypothyroidism, HT exert opposite risks for postmenopausal breast cancer

Hypothyroidism, HT exert opposite risks for postmenopausal breast cancer

In a large prospective cohort of postmenopausal women, those who had ever had hypothyroidism — whether treated with levothyroxine or not — were less likely to develop breast cancer than those without hypothyroidism, and the relationship was more pronounced among those who did not also use menopausal hormone therapy, according to findings published in Thyroid.

View more